Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Accepted on 17 Jan 2025

Analysis of the Prognostic Value of Thyroglobulin Antibody Change Trends During Follow-up After 131 I Treatment in Patients with Differentiated Thyroid Carcinoma

in Molecular and Cellular Oncology

Hua Ge
Wenxin Chen
Zhiyi Lin
Yuxuan Li
Shuting Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1496594

Correction

Published on 17 Jan 2025

Corrigendum: ATG5 and ATG7 expression levels are reduced in cutaneous melanoma and regulated by NRF1

in Molecular and Cellular Oncology

Živa Frangež
Deborah Gérard
Zhaoyue He
Marios Gavriil
Yuniel Fernández-Marrero
S. Morteza Seyed Jafari
Robert E. Hunger
Philippe Lucarelli
Shida Yousefi
Thomas Sauter

Frontiers in Oncology

doi 10.3389/fonc.2025.1549776

Review

Published on 15 Jan 2025

Unveiling hotspots of emerging research in the miRNA-related mechanism underlying cancer through comprehensive bibliometric analysis with implications for precision medicine and non-invasive diagnostics

in Molecular and Cellular Oncology

Zhirui Zhang
Wenhuan Song
Wenyu Chen
Wenze Cui
Wenyi Chen
Qinheng Zhang
Wenwen Ji
Yinglin Wang
Jiayi Wang
Wenhao Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1521251

182 views

Review

Published on 14 Jan 2025

Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments

in Molecular and Cellular Oncology

Edgar Yebran Villegas-Vazquez
Francisco Pável Marín-Carrasco
Octavio Daniel Reyes-Hernández
Andrea S. Báez-González
Lilia Patricia Bustamante-Montes
Teresita Padilla-Benavides
Laura Itzel Quintas-Granados
Gabriela Figueroa-González

Frontiers in Oncology

doi 10.3389/fonc.2024.1514120

419 views

Original Research

Published on 13 Jan 2025

Serum stromal cell-derived factor 1α as a prognostic indicator in elderly patients with acute myeloid leukemia receiving CAG-based chemotherapy

in Molecular and Cellular Oncology

Zhenzhen Wang
Jing Yuan
Nan Zhou
Jianfeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1521179

236 views

Original Research

Published on 13 Jan 2025

The role of VANGL2 in glioma oncogenesis and progression: insights into expression profiles and prognostic relevance

in Molecular and Cellular Oncology

Mingyu Zhao
Shanshuang Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1527226

205 views

Review

Accepted on 10 Jan 2025

Research progress of circRNAs in bone-related diseases

in Molecular and Cellular Oncology

Xianming Hua
Lingfeng Yu
Hao Zhu
Yan Zhu
Gentao Fan
Guangxin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1481322

Review

Accepted on 10 Jan 2025

CircRNAs in Colorectal Cancer: Potential Roles, Clinical Applications, and Natural Product-Based Regulation

in Molecular and Cellular Oncology

Jingjing Yang
Qiqi Fan
Yiyun Wang
Yuanyue Liu
Xiaoning Xu
Yeqi Liang
Jiakang Xie
Jiajie Li
Fengting Ai
Yong Cao

Frontiers in Oncology

doi 10.3389/fonc.2025.1525779

Clinical Trial

Published on 09 Jan 2025

Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets

in Molecular and Cellular Oncology

Tomasz Sirek
Katarzyna Król-Jatręga
Przemysław Borawski
Nikola Zmarzły
Dariusz Boroń
Piotr Ossowski
Olga Nowotny-Czupryna
Kacper Boroń
Dominika Janiszewska-Bil
Elżbieta Mitka-Krysiak

Frontiers in Oncology

doi 10.3389/fonc.2024.1515387

189 views

Review

Published on 09 Jan 2025

Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy

in Molecular and Cellular Oncology

Qixuan Feng
Yue Sun
Zhe Yang
Zhiyu Wang
Zhangyi Chen
Fang Liu
Lingxiang Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1522919

Original Research

Accepted on 07 Jan 2025

Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer

in Molecular and Cellular Oncology

Chujin Ye
Yanlin Tang
Jiayi Zeng
Chujin Ye
Jiumin Liu
Haibiao Xie

Frontiers in Oncology

doi 10.3389/fonc.2025.1443571

Review

Published on 07 Jan 2025

REV7: a small but mighty regulator of genome maintenance and cancer development

in Molecular and Cellular Oncology

Lara R. Maggs
Mitch McVey

Frontiers in Oncology

doi 10.3389/fonc.2024.1516165

196 views

Case Report

Accepted on 06 Jan 2025

Rare Case Report: Sclerosing Epithelioid Fibrosarcoma with FUS-CREB3L1 Gene Fusion

in Molecular and Cellular Oncology

Tingting Wang
Haimin Xu
Chuanying Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1491398

Review

Accepted on 06 Jan 2025

Interactions Between Key Genes and Pathways in Prostate Cancer Progression and Therapy Resistance

in Molecular and Cellular Oncology

Fan Wu
Hengsen Zhang
Miaomiao Hao

Frontiers in Oncology

doi 10.3389/fonc.2025.1467540

Original Research

Published on 06 Jan 2025

Downregulation of hnRNPA1 inhibits hepatocellular carcinoma cell progression by modulating alternative splicing of ZNF207 exon 9

in Molecular and Cellular Oncology

Qi Ouyang
Wenhui He
Yiping Guo
Lin Li
Ying Mao
Xiang Li
Shuanglin Xiang
Xiang Hu
Jun He

Frontiers in Oncology

doi 10.3389/fonc.2024.1517459

213 views

Review

Accepted on 02 Jan 2025

Immunoregulatory Role of Exosomal CircRNAs in the Tumor Microenvironment

in Molecular and Cellular Oncology

Cunming Lv
Xinyu Wei
Yichen Lin

Frontiers in Oncology

doi 10.3389/fonc.2025.1453786

109 views

Navigation group

Articles

Analysis of the Prognostic Value of Thyroglobulin Antibody Change Trends During Follow-up After 131 I Treatment in Patients with Differentiated Thyroid Carcinoma

Corrigendum: ATG5 and ATG7 expression levels are reduced in cutaneous melanoma and regulated by NRF1

Unveiling hotspots of emerging research in the miRNA-related mechanism underlying cancer through comprehensive bibliometric analysis with implications for precision medicine and non-invasive diagnostics

Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments

Serum stromal cell-derived factor 1α as a prognostic indicator in elderly patients with acute myeloid leukemia receiving CAG-based chemotherapy

The role of VANGL2 in glioma oncogenesis and progression: insights into expression profiles and prognostic relevance

Research progress of circRNAs in bone-related diseases

CircRNAs in Colorectal Cancer: Potential Roles, Clinical Applications, and Natural Product-Based Regulation

Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets

Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy

Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer

REV7: a small but mighty regulator of genome maintenance and cancer development

Rare Case Report: Sclerosing Epithelioid Fibrosarcoma with FUS-CREB3L1 Gene Fusion

Interactions Between Key Genes and Pathways in Prostate Cancer Progression and Therapy Resistance

Downregulation of hnRNPA1 inhibits hepatocellular carcinoma cell progression by modulating alternative splicing of ZNF207 exon 9

Immunoregulatory Role of Exosomal CircRNAs in the Tumor Microenvironment